查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012904

血袋市場：2026-2032年全球市場預測（按產品類型、滅菌方法、材料類型、填充容量、應用、最終用戶和分銷管道分類）

Blood Bags Market by Product Type, Sterilization Method, Material Type, Fill Volume, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血袋市場價值將達到 5.9009 億美元，到 2026 年將成長至 6.2142 億美元，到 2032 年將達到 9.6819 億美元，複合年成長率為 7.32%。

主要市場統計數據
基準年 2025 590,090,000 美元
預計年份：2026年 6.2142億美元
預測年份 2032 9.6819億美元
複合年成長率 (%) 7.32%

背景概述，闡述了塑造現代血袋生態系統的臨床重點、供應連續性挑戰、監管限制和採購要求。

血袋產業處於臨床安全、供應鏈複雜性以及不斷發展的材料和滅菌技術的關鍵交匯點。現代醫療保健系統依賴可靠的血液收集、儲存和輸血耗材來支持急診護理、擇期手術和持續治療性介入。因此，該行業的格局受到嚴格的監管要求、對可追溯性和無菌性的重視以及對能夠應對突發需求激增的互通性供應網路的需求的影響。

材料創新、滅菌技術的進步、更嚴格的法規以及永續性的壓力如何重塑產品設計、供應商趨勢和籌資策略。

血袋市場正經歷一場變革，其驅動力包括材料創新、滅菌技術進步以及監管力道加大。聚合物和添加劑的創新旨在提高生物相容性並減少滲漏，而替代滅菌方法則旨在保持組件完整性並延長保存期限。同時，監管機構正在完善可追溯性和標籤要求，這增加了製造商和經銷商的行政負擔，同時也加速了標準化條碼和電子追蹤系統的應用。

本研究評估了累積關稅波動和不斷變化的貿易政策如何加劇供應鏈風險、影響製造業決策並迫使各行業調整其策略採購結構。

關稅和貿易政策調整的累積影響正對血袋生態系統內的供應連續性、成本結構和籌資策略產生重大影響。關稅調整增加了進口聚合物樹脂、製造原料和成品的接收成本，促使買家和製造商考慮近岸外包、雙重採購和庫存調整等緩解措施。同時，貿易規則變化帶來的行政複雜性加劇了前置作業時間的波動，並使供應商資格合格流程更加複雜，尤其對於那些依賴跨境供應鏈獲取關鍵零件的公司而言更是如此。

全面的細分洞察，揭示了產品、滅菌、材料、產能、應用、最終用戶和分銷管道等因素，指南優先順序和創新決策。

詳細的市場細分分析能夠清楚闡明影響採購和產品開發決策的各項變量，例如產品、流程、材料、填充量、臨床應用、最終用戶和分銷管道。根據產品類型，市場被細分為雙聯血袋、四聯血袋、五聯血袋、單聯血袋和三聯血袋，每種規格都有不同的臨床工作流程相容性和成分分離要求。根據滅菌方法，市場細分為電子束滅菌、環氧乙烷滅菌、伽馬射線滅菌和蒸氣滅菌，滅菌方式的選擇會影響產品的保存期限、成分完整性和驗證的複雜性。根據材料類型，市場被細分為聚對苯二甲酸乙二醇酯 (PET)、聚烯、聚丙烯 (PP) 和聚氯乙烯(PVC)，材料的選擇會影響產品的焊接性、透氣滲透性以及與萃取物和洗脫液相關的監管審查。

區域分析概述了美洲、歐洲、中東和非洲以及亞太地區如何為供應商和買家創造獨特的監管、商業和物流要求。

區域趨勢對管理體制、供應商網路和臨床部署路徑有顯著影響，從而在每個區域形成了獨特的策略重點。在採購中心集中的美洲地區，聯邦和州機構之間的監管協調至關重要，大規模醫院網路和中央血庫的推動使得與自動化血液成分分離技術的兼容性成為迫切需求。在歐洲、中東和非洲（EMEA）地區，多樣化的報銷模式、採購流程和分散的監管環境要求供應商在滿足不同基礎架構層的同時，保持靈活的監管策略和區域適應性的品管系統。在亞太地區，醫療保健系統的快速現代化和大規模公共衛生宣傳活動需要擴充性的生產系統、經濟高效的材料以及能夠覆蓋廣闊地理區域的分銷網路。

產業相關人員正在深入了解監管專業知識、生產規模、滅菌能力和供應鏈可靠性如何為競爭優勢做出貢獻。

隨著老牌製造商、專業無菌組件製造商和契約製造製造商尋求差異化的價值提案，強調監管專業知識、成熟的品質系統和在地化生產能力，競爭格局正在改變。大型供應商利用規模經濟，投資於流程自動化、拓展產品系列和全球品質標準化，而規模小規模的利基企業則憑藉敏捷性、專業化的產品形式和針對特定臨床工作流程量身定做的本地化服務模式展開競爭。材料供應商和醫療設備製造商之間的策略夥伴關係日益普遍，這些合作正在加速材料合格，並縮短新產品上市前的合規時間。

為產業領導者提供切實可行的策略步驟，以加強監管合規性、實現製造地多元化、提高可追溯性並加強與供應商的夥伴關係。

產業領導者應採取多管齊下的策略，平衡創新、監管合作和供應鏈韌性，將當前壓力轉化為永續的競爭優勢。優先發展能夠預測監管預期並縮短新產品變更核准時間的材料和滅菌驗證項目。同時，應實現製造地多元化或與區域契約製造製造商建立策略夥伴關係，以降低貿易政策風險並縮短前置作業時間。

透過結合相關人員訪談、監管分析和供應鏈診斷的透明混合研究途徑，可以得出檢驗且可操作的見解。

本研究採用混合方法，結合質性專家訪談、監管文件分析和二手文獻綜述，綜合得出結果，從而提供平衡且以證據為基礎的觀點。研究人員從臨床醫生、採購負責人、法規遵循專家和生產負責人處收集了關鍵的定性信息，以了解實際運營情況、產品性能預期和採購限制。為了補充這些訪談，研究人員還對監管指南、滅菌標準和材料安全評估進行了嚴格的分析，以檢驗技術假設並識別合規性方面的挑戰。

簡潔扼要的結論強調了材料、消毒、監管和供應鏈策略的關鍵交叉點，這些交叉點決定了韌性和競爭優勢。

總而言之，由於材料科學、滅菌技術、法規和貿易政策趨勢的不斷發展，血袋產業正處於策略轉折點，產品設計、供應商競爭和採購方式都受到了影響。積極主動地透過加強驗證流程、實現採購多元化和提高可追溯性來適應變化的相關人員，將更有利於確保臨床服務的連續性，並抓住源於產品差異化和服務卓越的成長機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 血袋市場：依產品類型分類

  • 兩袋血袋
  • 四袋裝血袋
  • 5個裝血袋
  • 單血袋
  • 三袋血

第9章 依滅菌方法分類的血袋市場

  • 電子束
  • 環氧乙烷
  • 伽瑪射線滅菌
  • 蒸氣滅菌

第10章：血袋市場：依材料類型分類

  • 聚對苯二甲酸乙二醇酯（PET）
  • 聚烯
  • 聚丙烯（PP）
  • 聚氯乙烯（PVC）

第11章 以填充容量分類的血包市場

  • 300～450 mL
  • 超過 450 毫升
  • 300毫升或以下

第12章 血袋市場：依應用領域分類

  • 血液成分分離
  • 捐血
  • 血液保存
  • 輸血

第13章 血袋市場：依最終用戶分類

  • 血庫
  • 測試機構
  • 醫院和診所
  • 研究機構

第14章 血袋市場：依通路分類

  • 離線
  • 線上

第15章 血袋市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 血袋市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 血袋市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國血袋市場

第19章：中國血袋市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdvaCare Pharma
  • Advin Health Care
  • Alvedia
  • BL Lifesciences Private Limited
  • Demophorius Limited
  • Fresenius SE & Co. KGaA
  • Grifols, SA
  • HAEMONETICS CORPORATION
  • HLL Lifecare Limited
  • HANSLER MEDICAL GMBH
  • Inovet
  • JMS Co., Ltd.
  • KIEFEL GmbH
  • Lmb Technologie GmbH
  • Maco Pharma SAS
  • Mitra Industries Pvt. Ltd.
  • Narang Medical Limited
  • Neomedic
  • Olidef Medical
  • Poly Medicure Limited
  • Qingdao Sinoland International Trade Co., Ltd.
  • RENOLIT SE
  • SB-Kawasumi Laboratories, Inc.
  • Shandong Weigao Group Medical Polymer Co.,Ltd.
  • Suru International Pvt. Ltd.
  • Suzhou Sinomed Co., Ltd.
  • Terumo Corporation
  • The Metrix Company
  • TROGE MEDICAL GmbH
  • Xindray Medical International Co., Ltd.
Product Code: MRR-437D45958098

The Blood Bags Market was valued at USD 590.09 million in 2025 and is projected to grow to USD 621.42 million in 2026, with a CAGR of 7.32%, reaching USD 968.19 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 590.09 million
Estimated Year [2026] USD 621.42 million
Forecast Year [2032] USD 968.19 million
CAGR (%) 7.32%

A contextual introduction that frames clinical priorities, supply continuity challenges, regulatory constraints, and procurement imperatives shaping the modern blood bags ecosystem

The blood bags sector occupies a critical intersection between clinical safety imperatives, supply chain complexity, and evolving material and sterilization technologies. Contemporary healthcare systems rely on robust blood collection, storage, and transfusion consumables to support emergency medicine, elective surgery, and ongoing therapeutic interventions. As a result, the landscape is shaped by rigorous regulatory expectations, an emphasis on traceability and sterility assurance, and the need for interoperable supply networks that can respond to episodic demand surges.

Over recent years, procurement teams and clinical leaders have prioritized product reliability, compatibility with component separation workflows, and supplier continuity. In addition, increased scrutiny on materials and sterilization pathways has influenced purchasing specifications and validation protocols. These dynamics are further complicated by global trade flows and regional regulatory divergence, requiring organizations to adopt more comprehensive sourcing strategies.

Given these complexities, stakeholders must balance clinical performance, patient safety, and logistical efficiency. Consequently, strategic planning now focuses on modular procurement, cross-compatible product suites, and enhanced supplier qualification processes. This introduction establishes a foundation for more detailed analysis of shifts in technology, trade policy impacts, segmentation patterns, and regional differentiators that follow in the subsequent sections.

How material innovation, sterilization advancements, regulatory tightening, and sustainability pressures are reshaping product design, supplier dynamics, and procurement strategies

The blood bags market is undergoing transformative shifts driven by material innovation, sterilization advances, and heightened regulatory scrutiny. Innovations in polymers and additive materials seek to improve biocompatibility and reduce leachables, while alternative sterilization methods aim to preserve component integrity and extend usable life. At the same time, regulatory authorities are refining traceability and labeling requirements, increasing the administrative burden on manufacturers and distributors and encouraging the adoption of standardized barcoding and electronic tracking systems.

As a result, suppliers are investing in process modernization and quality management systems to meet these expectations, which in turn reshapes competitive dynamics and entry barriers. Meanwhile, clinical pathways are adapting to new component separation techniques and single-donor processing protocols, prompting demand for product formats that offer greater modularity and compatibility with automated systems. These technological and regulatory currents are compounded by sustainability concerns that press manufacturers to reconsider material selection and end-of-life disposal practices.

Consequently, stakeholder strategies are shifting from transactional procurement to long-term partnerships centered on product lifecycle assurance, regulatory alignment, and operational resilience. In the near term, these converging trends will continue to influence product design priorities, capital investment decisions, and the configuration of distribution networks across both domestic and international channels.

Assessing how cumulative tariff shifts and evolving trade policies amplify supply chain risk, influence manufacturing decisions, and compel strategic sourcing adaptations across the industry

The cumulative impact of tariffs and trade policy recalibrations has material consequences for supply continuity, cost structures, and sourcing strategies within the blood bags ecosystem. Tariff adjustments increase landed costs for imported polymer resins, manufacturing inputs, and finished goods, prompting purchasers and manufacturers to evaluate nearshoring, dual-sourcing, and inventory rebalancing as mitigations. In parallel, administrative complexity stemming from changed trade rules elevates lead time variability and complicates supplier qualification processes, especially for entities that rely on cross-border supply chains for critical components.

As tariffs reshape the economics of manufacturing locations, some producers will reassess the viability of offshore production versus regional manufacturing footprints that reduce exposure to trade volatility. Procurement teams may prioritize suppliers with diversified manufacturing bases and transparent cost structures to maintain stable inventories and predictable pricing. Moreover, extended approval cycles and customs compliance requirements can delay product availability, which increases the importance of proactive regulatory engagement and scenario planning.

Therefore, organizations must integrate tariff sensitivity into commercial planning, supplier contracting, and contingency inventories. By doing so, they can protect clinical operations from supply disruption and support clinical continuity even as trade policies evolve. Ultimately, the cumulative effect of tariffs is to elevate strategic emphasis on supply chain resilience, regulatory agility, and collaborative supplier relationships.

Comprehensive segmentation insights that reveal product, sterilization, material, volume, application, end-user, and channel drivers which inform prioritization and innovation decisions

A granular segmentation view provides actionable clarity across product, process, material, fill volume, clinical application, end-user, and distribution channel variables that drive procurement and product development decisions. Based on Product Type, market is studied across Double Blood Bags, Quadruple Blood Bags, Quintuple Blood Bags, Single Blood Bags, and Triple Blood Bags, and each format presents different clinical workflow compatibility and component separation requirements. Based on Sterilization Method, market is studied across Electron Beam, Ethylene Oxide, Gamma Irradiation, and Steam Sterilization, and the selection of sterilization pathways impacts shelf life, component integrity, and validation complexity. Based on Material Type, market is studied across Polyethylene Terephthalate (PET), Polyolefin, Polypropylene (PP), and Polyvinyl Chloride (PVC), and material choice affects weldability, gas permeability, and regulatory scrutiny regarding extractables and leachables.

Based on Fill Volume, market is studied across 300-450 mL, Above 450 mL, and Up To 300 mL, and volume preferences correlate with procedural use cases and donor management protocols. Based on Application, market is studied across Blood Component Separation, Blood Donation, Blood Storage, and Blood Transfusion, and these applications impose distinct design and compatibility specifications. Based on End User, market is studied across Blood Banks, Diagnostic Laboratories, Hospitals & Clinics, and Research Institutes, and each end-user group prioritizes different performance attributes, inventory models, and regulatory compliance needs. Based on Distribution Channel, market is studied across Offline and Online, and channel selection influences lead times, contract terms, and aftermarket services.

Together, these segmentation lenses clarify where innovation and investment will have the greatest operational impact, enabling product teams and procurement leaders to align development roadmaps and sourcing strategies with specific clinical and logistical requirements.

Regional analysis outlining how Americas, Europe, Middle East & Africa, and Asia-Pacific each create unique regulatory, commercial, and logistical imperatives for suppliers and purchasers

Regional dynamics exert a pronounced influence on regulatory regimes, supplier networks, and clinical adoption pathways, producing distinct strategic priorities in each geography. Americas demonstrates concentrated procurement hubs, an emphasis on regulatory harmonization across federal and state agencies, and a strong demand for compatibility with automated blood component separation technologies driven by large hospital networks and centralized blood centers. Europe, Middle East & Africa presents a fragmented regulatory landscape with varying reimbursement models and procurement processes, requiring suppliers to maintain flexible regulatory strategies and localized quality systems while addressing diverse clinical infrastructure levels. Asia-Pacific displays a mix of rapidly modernizing healthcare systems and high-volume public health campaigns that prioritize scalable production, cost-effective materials, and distribution networks capable of servicing wide geographic territories.

As a consequence, manufacturers and distributors must tailor commercial models to regional realities, investing in targeted regulatory dossiers, localized customer support, and supply chain nodes that reduce lead times. In addition, cross-regional partnerships and contract manufacturing arrangements can bridge capability gaps and ensure continuity of supply during demand surges or regulatory transitions. Ultimately, recognizing and responding to these regional differentiators is essential for sustained commercial performance and for meeting the varied clinical requirements across different health systems.

Insights into how competitive advantages are shaped by regulatory expertise, manufacturing scale, sterilization capability, and supply chain reliability among industry participants

Competitive dynamics are evolving as established manufacturers, specialized sterile component producers, and contract manufacturers pursue differentiated value propositions that emphasize regulatory expertise, quality system maturity, and local manufacturing capabilities. Large-tier suppliers leverage scale to invest in process automation, extended product portfolios, and global quality harmonization, while smaller niche players compete through agility, specialized product formats, and localized service models that meet specific clinical workflows. Strategic partnerships between material suppliers and device manufacturers are becoming more common, and these collaborations accelerate material qualification and reduce time-to-compliance for new product introductions.

Moreover, investments in sterilization capacity and validation services give suppliers advantages in contracts that require expedited qualification paths or bespoke sterilization solutions. Distribution partners with proven cold chain and logistics capabilities differentiate themselves by reducing inventory risk and improving replenishment predictability for high-volume end users. Consequently, the competitive landscape rewards firms that combine technical differentiation with supply chain reliability and regulatory responsiveness. For customers, this means that supplier selection increasingly hinges on demonstrable quality performance, transparency in supply provenance, and the ability to provide end-to-end lifecycle support.

Actionable strategic steps for industry leaders to strengthen regulatory readiness, diversify manufacturing footprints, enhance traceability, and fortify supplier partnerships

Industry leaders should adopt a multi-pronged strategy that balances innovation, regulatory engagement, and supply chain resilience to convert current pressures into durable competitive advantages. Prioritize material and sterilization validation programs that anticipate regulatory expectations and reduce time-to-approval for new product variants. Simultaneously, diversify manufacturing footprints or establish strategic partnerships with regional contract manufacturers to mitigate trade policy exposure and compress lead times.

In parallel, invest in traceability and digital inventory systems that support clinical traceability and enable predictive replenishment across distributed networks. Strengthen supplier qualification criteria to include contingency capacity, multi-region production capability, and transparent cost components tied to trade sensitivities. Finally, develop commercial models that emphasize lifecycle services, training, and interoperability with component separation systems, thereby increasing switching costs for buyers and deepening collaborative relationships.

By implementing these initiatives, industry leaders can protect clinical continuity, support regulatory compliance, and create differentiated offerings that align with evolving hospital and blood center priorities. These recommendations translate strategic intent into operational steps that support both near-term risk mitigation and sustained market positioning.

A transparent mixed-methods research approach combining stakeholder interviews, regulatory analysis, and supply chain diagnostics to produce validated actionable insights

This research synthesis is grounded in a mixed-methods approach that combined qualitative expert interviews, regulatory document analysis, and secondary literature review to produce a balanced, evidence-based perspective. Primary qualitative inputs were collected from clinicians, procurement professionals, regulatory affairs specialists, and manufacturing leaders to capture operational realities, product performance expectations, and sourcing constraints. Complementing these interviews, rigorous analysis of regulatory guidance, sterilization standards, and material safety assessments was conducted to validate technical assumptions and identify compliance-related pressures.

Additionally, supply chain diagnostic workstreams examined trade flows, manufacturing footprints, and distribution channel architectures to surface vulnerability points and resilience opportunities. Where appropriate, triangulation across independent data sources ensured that observations reflect convergent evidence rather than isolated anecdotes. Throughout the process, emphasis was placed on transparency of assumptions and reproducibility of analytical steps, enabling readers to trace how conclusions were derived and to adapt the methodology for bespoke follow-on studies.

This methodology supports strategic decision-making by combining operational insight with technical validation, providing stakeholders with a robust basis for procurement, product development, and regulatory engagement activities.

A concise conclusion emphasizing the critical intersection of material, sterilization, regulatory, and supply chain strategies that determine resilience and competitive positioning

In summary, the blood bags sector is at a strategic inflection point where material science, sterilization practice, regulatory evolution, and trade policy dynamics collectively influence product design, supplier competition, and procurement approaches. Stakeholders who proactively adapt by strengthening validation pathways, diversifying sourcing footprints, and enhancing traceability will be better positioned to ensure clinical continuity and capture growth opportunities rooted in product differentiation and service excellence.

Moving forward, the interplay between regional regulatory frameworks and supply chain configuration will determine competitive advantage, and organizations that invest in regional manufacturing partnerships and robust quality systems will mitigate disruption risk. In addition, a focus on interoperable product formats and lifecycle support services will increase the value proposition for clinical buyers, fostering longer-term relationships and more predictable demand patterns.

Ultimately, disciplined execution of the strategies and recommendations outlined herein will enable organizations to navigate near-term headwinds while investing in capabilities that sustain long-term operational resilience and clinical alignment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Bags Market, by Product Type

  • 8.1. Double Blood Bags
  • 8.2. Quadruple Blood Bags
  • 8.3. Quintuple Blood Bags
  • 8.4. Single Blood Bags
  • 8.5. Triple Blood Bags

9. Blood Bags Market, by Sterilization Method

  • 9.1. Electron Beam
  • 9.2. Ethylene Oxide
  • 9.3. Gamma Irradiation
  • 9.4. Steam Sterilization

10. Blood Bags Market, by Material Type

  • 10.1. Polyethylene Terephthalate (PET)
  • 10.2. Polyolefin
  • 10.3. Polypropylene (PP)
  • 10.4. Polyvinyl Chloride (PVC)

11. Blood Bags Market, by Fill Volume

  • 11.1. 300-450 mL
  • 11.2. Above 450 mL
  • 11.3. Up To 300 mL

12. Blood Bags Market, by Application

  • 12.1. Blood Component Separation
  • 12.2. Blood Donation
  • 12.3. Blood Storage
  • 12.4. Blood Transfusion

13. Blood Bags Market, by End User

  • 13.1. Blood Banks
  • 13.2. Diagnostic Laboratories
  • 13.3. Hospitals & Clinics
  • 13.4. Research Institutes

14. Blood Bags Market, by Distribution Channel

  • 14.1. Offline
  • 14.2. Online

15. Blood Bags Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Blood Bags Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Blood Bags Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Blood Bags Market

19. China Blood Bags Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AdvaCare Pharma
  • 20.6. Advin Health Care
  • 20.7. Alvedia
  • 20.8. B L Lifesciences Private Limited
  • 20.9. Demophorius Limited
  • 20.10. Fresenius SE & Co. KGaA
  • 20.11. Grifols, S.A
  • 20.12. HAEMONETICS CORPORATION
  • 20.13. HLL Lifecare Limited
  • 20.14. HANSLER MEDICAL GMBH
  • 20.15. Inovet
  • 20.16. JMS Co., Ltd.
  • 20.17. KIEFEL GmbH
  • 20.18. Lmb Technologie GmbH
  • 20.19. Maco Pharma SAS
  • 20.20. Mitra Industries Pvt. Ltd.
  • 20.21. Narang Medical Limited
  • 20.22. Neomedic
  • 20.23. Olidef Medical
  • 20.24. Poly Medicure Limited
  • 20.25. Qingdao Sinoland International Trade Co., Ltd.
  • 20.26. RENOLIT SE
  • 20.27. SB-Kawasumi Laboratories, Inc.
  • 20.28. Shandong Weigao Group Medical Polymer Co.,Ltd.
  • 20.29. Suru International Pvt. Ltd.
  • 20.30. Suzhou Sinomed Co., Ltd.
  • 20.31. Terumo Corporation
  • 20.32. The Metrix Company
  • 20.33. TROGE MEDICAL GmbH
  • 20.34. Xindray Medical International Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD BAGS MARKET SIZE, BY DOUBLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD BAGS MARKET SIZE, BY DOUBLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD BAGS MARKET SIZE, BY DOUBLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD BAGS MARKET SIZE, BY QUADRUPLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD BAGS MARKET SIZE, BY QUADRUPLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD BAGS MARKET SIZE, BY QUADRUPLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD BAGS MARKET SIZE, BY QUINTUPLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD BAGS MARKET SIZE, BY QUINTUPLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD BAGS MARKET SIZE, BY QUINTUPLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD BAGS MARKET SIZE, BY SINGLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD BAGS MARKET SIZE, BY SINGLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD BAGS MARKET SIZE, BY SINGLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD BAGS MARKET SIZE, BY TRIPLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD BAGS MARKET SIZE, BY TRIPLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD BAGS MARKET SIZE, BY TRIPLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD BAGS MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD BAGS MARKET SIZE, BY ELECTRON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD BAGS MARKET SIZE, BY ELECTRON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD BAGS MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD BAGS MARKET SIZE, BY GAMMA IRRADIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD BAGS MARKET SIZE, BY GAMMA IRRADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD BAGS MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD BAGS MARKET SIZE, BY STEAM STERILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD BAGS MARKET SIZE, BY STEAM STERILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYPROPYLENE (PP), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYPROPYLENE (PP), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYPROPYLENE (PP), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD BAGS MARKET SIZE, BY 300-450 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD BAGS MARKET SIZE, BY 300-450 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD BAGS MARKET SIZE, BY 300-450 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD BAGS MARKET SIZE, BY ABOVE 450 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD BAGS MARKET SIZE, BY ABOVE 450 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD BAGS MARKET SIZE, BY ABOVE 450 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD BAGS MARKET SIZE, BY UP TO 300 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD BAGS MARKET SIZE, BY UP TO 300 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD BAGS MARKET SIZE, BY UP TO 300 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD DONATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD DONATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD DONATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD BAGS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD BAGS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD BAGS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD BAGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD BAGS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD BAGS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD BAGS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD BAGS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD BAGS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD BAGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD BAGS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD BAGS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD BAGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD BAGS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD BAGS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BLOOD BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BLOOD BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. GCC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GCC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. GCC BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 164. GCC BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 166. GCC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. GCC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. GCC BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. G7 BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. G7 BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. G7 BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 188. G7 BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 190. G7 BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. G7 BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. G7 BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. NATO BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. NATO BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. NATO BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 196. NATO BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 198. NATO BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. NATO BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. NATO BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)